Global Contrast Media/Contrast Agents Market Outlook 2019-2024 - Opportunities Presented by Generic Contrast Media & Increasing Research
DUBLIN, Dec. 18, 2019 /PRNewswire/ -- The "Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global contrast media market is expected to reach USD 6,047.3 million by 2024 from an estimated USD 5,024.1 million in 2019, at a CAGR of 3.8% during the forecast period.
GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany),Guerbet (France), Lantheus (US) were the leading players in the contrast media market.
Contrast media/contrast agents market is projected to grow at a CAGR of 3.8%.
The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide.
Growth in the market can primarily be attributed to factors such as the increasing number of approvals for contrast agents and the rising volume of CT and MRI examinations globally. The growing number of research & funding activities for contrast agents and their applications provide immense opportunities for players in the contrast media market.
The X-ray/CT procedures segment to hold the largest contrast media market share in 2019.
Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.
The cardiovascular disorders segment is projected to grow at the highest CAGR during the forecast period.
Based on the indication, the contrast media market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and
strong healthcare infrastructure in developed countries are some of the factors driving this segment.
Asia-Pacific to witness the highest growth during the forecast period.
Asia-Pacific is expected to grow at the highest CAGR during the forecast period of 2019-2024. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the contrast media market in this region.
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Contrast Media Market Overview
4.2 European Contrast Media Market, By Modality (2019)
4.3 Contrast Media Market Share, By Modality, 2019 vs. 2024
4.4 Contrast Media Market Share, By Route of Administration, 2019 vs. 2024
4.5 Contrast Media Market Share, By Indication, 2019 vs. 2024
4.6 Contrast Media Market Share, By Application, 2019 vs. 2024
4.7 Contrast Media Market Share, By Type, 2019 vs. 2024
4.8 Geographic Snapshot: Contrast Media Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cancer and Cvds
5.2.1.2 Approvals of Contrast Agents
5.2.1.3 Increasing Demand for Early Diagnosis and Rising Volume of Ct and Mri Examinations
5.2.2 Restraints
5.2.2.1 Side-Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunities
5.2.3.1 Generic Contrast Media
5.2.3.2 Increasing Research
5.2.4 Challenges
5.2.4.1 Technological Advancements in Imaging Solutions
5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents
6 Contrast Media/Contrast Agents Market, By Type
6.1 Introduction
6.2 Iodinated Contrast Media
6.2.1 Extensive Usage of Iodinated Contrast Media in Ct Examinations is A Key Factor Supporting Market Growth
6.3 Gadolinium-Based Contrast Media
6.3.1 APAC is the Fastest-Growing Market for Gadolinium-Based Contrast Media
6.4 Microbubble Contrast Media
6.4.1 Microbubble Contrast Media to Register the Highest Growth Rate During the Forecast Period
6.5 Barium-Based Contrast Media
6.5.1 Barium-Based Contrast Media Can Cause Adverse Effects in Patients, Owing to Which the Market is Projected to Decline
7 Contrast Media/Contrast Agents Market, By Modality
7.1 Introduction
7.2 X-Ray/Ct
7.2.1 X-Ray/Ct Accounts For The Largest Share of the Contrast Media Market
7.3 Magnetic Resonance Imaging
7.3.1 Growing Number of Mri Scanners and Increasing Mri Examinations are Likely to Drive Market Growth
7.4 Ultrasound
7.4.1 Ultrasound Contrast Agents Will Register the Highest Growth Rate During the Forecast Period
8 Contrast Media/Contrast Agents Market, By Indication
8.1 Introduction
8.2 Cardiovascular Diseases
8.2.1 Cardiovascular Diseases Segment to Dominate the Contrast Media Market
8.3 Cancer
8.3.1 Asia Pacific is Expected to Register Relatively Higher Growth Owing to the High Cancer Prevalence in the Region
8.4 Gastrointestinal Disorders
8.4.1 Rising Prevalence of Gi Disorders to Support Market Growth
8.5 Musculoskeletal Disorders
8.5.1 Rising Incidence of Work-Related Musculoskeletal Disorders to Support Market Growth
8.6 Neurological Disorders
8.6.1 Rising Prevalence of Dementia Worldwide to Support Market Growth
8.7 Nephrological Disorders
8.7.1 Rising Prevalence of Esrd is Driving the Demand for Diagnostic Tools for Kidney Diseases
9 Contrast Media/Contrast Agents Market, By Route of Administration
9.1 Introduction
9.2 Intravascular Route
9.2.1 Intravascular Route of Administration is Expected to Grow at the Highest CAGR During the Forecast Period
9.2.1.1 Intravenous (IV)
9.2.1.2 Intra-Arterial (IA)
9.3 Oral Route
9.3.1 North America to Dominate the Contrast Media Market for Oral Route of Administration
9.4 Rectal Route
9.4.1 Contrast Agents Administered Rectally are Liquid E-Z-Paque, Liquid Polibar Plus, and Micropaque
9.5 Other Routes of Administration
10 Contrast Media/Contrast Agents Market, By Application
10.1 Introduction
10.2 Radiology
10.2.1 Growing Number of Diagnostic Procedures to Drive the Contrast Media Market for Radiology Applications
10.3 Interventional Radiology
10.3.1 Increasing Popularity of Minimally Invasive Procedures to Support Market Growth
10.4 Interventional Cardiology
10.4.1 Rising Incidence of Cardiac Disorders to Drive the Demand for Interventional Cardiology Procedures
11 Contrast Media/Contrast Agents Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 The US Dominates the Global Contrast Media Market
11.2.2 Canada
11.2.2.1 Increasing Investments in Improving Medical Imaging - A Major Factor Driving Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Presence of A Well-Developed Diagnostic Imaging Infrastructure is A Major Factor Supporting Market Growth in Germany
11.3.2 France
11.3.2.1 Increasing Prevalence of Cancer Will Drive the Market for Contrast Media in France
11.3.3.1 Increasing Investments in the Field of Diagnostic Imaging to Boost Market Growth
11.3.4 Italy
11.3.4.1 Growing Prevalence of Cancer and Obesity Will Drive the Demand for Diagnostic Procedures in Italy
11.3.5 Spain
11.3.5.1 Shortage of Radiologists in the Country to Restrain Market Growth
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 Japan Dominates the APAC Contrast Media Market
11.4.2 China
11.4.2.1 High Incidence of Cancer and Strokes Will Support the Market for Contrast Media in China
11.4.3 India
11.4.3.1 Growing Investments in the Indian Radiology Market Will Propel Market Growth
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
12 Competitive Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Right-To-Win
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
12.5 Competitive Scenario
12.5.1 Product Launches & Approvals
12.5.2 Expansions
12.5.3 Acquisitions
12.5.4 Partnerships & Agreements
13 Company Profiles
13.1 GE Healthcare
13.2 Bracco Imaging S.P.A.
13.3 Bayer AG
13.4 Guerbet Group
13.5 Lantheus Medical Imaging, Inc.
13.6 Daiichi Sankyo
13.7 Unijules Life Sciences
13.8 J.B. Chemicals and Pharmaceuticals Ltd.
13.9 Sanochemia
13.10 Magnus Health
13.11 Taejoon Pharm
13.12 Jodas Expoim
13.13 Nano Therapeutics Pvt. Ltd.
13.14 Kiran X-Ray
13.15 Interpharma Praha A.S.
13.16 Imax Diagnostic Imaging Limited
13.17 Yangtze River Pharmaceutical Group (YRPG)
13.18 Spago Nanomedical AB
13.19 Subhra Pharma Pvt. Ltd.
13.20 M. Biotech Limited
13.21 Mri Contrast Agents: Product Comparison
13.22 CT Contrast Agents: Product Comparison
13.23 Ultrasound Contrast Agents: Product Comparison
For more information about this report visit https://www.researchandmarkets.com/r/e0g3tk
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article